{ "@context": "https://schema.org", "@type": "Organization", "name": "Brainscape", "url": "https://www.brainscape.com/", "logo": "https://www.brainscape.com/pks/images/cms/public-views/shared/Brainscape-logo-c4e172b280b4616f7fda.svg", "sameAs": [ "https://www.facebook.com/Brainscape", "https://x.com/brainscape", "https://www.linkedin.com/company/brainscape", "https://www.instagram.com/brainscape/", "https://www.tiktok.com/@brainscapeu", "https://www.pinterest.com/brainscape/", "https://www.youtube.com/@BrainscapeNY" ], "contactPoint": { "@type": "ContactPoint", "telephone": "(929) 334-4005", "contactType": "customer service", "availableLanguage": ["English"] }, "founder": { "@type": "Person", "name": "Andrew Cohen" }, "description": "Brainscape’s spaced repetition system is proven to DOUBLE learning results! Find, make, and study flashcards online or in our mobile app. Serious learners only.", "address": { "@type": "PostalAddress", "streetAddress": "159 W 25th St, Ste 517", "addressLocality": "New York", "addressRegion": "NY", "postalCode": "10001", "addressCountry": "USA" } }

Hepatitis Flashcards

(25 cards)

1
Q

Hbsag becomes undetectable _____ after onset of jaundice

A

after 1-2 mos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When does antiHBc appear in the serum

A

Within the first 1-2 weeks after appearance of HBsAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HbsAg levels detectable when

A

Within 1-12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HCV gains entry into the hepatocytes through this receptor

A

CD81 receptors

claudin-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Most sensitive HCV infection

A

HCV RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Entirely transmitted NonA NonB hepatitis

A

Hep E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

extrahepatic manifestations of Hep

A

serum-sickness like syndrome
GN
generalized vasculitis
essential mixed cryoglobulinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hep B; arthritis, cutaneous vasculitis (palpable purpura) +/- GN with circulating cryoprecipitable immune complexes of more than one immunoglobulin class

A

essential mixed cryoglobulinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

acidophilic degeneration of hepatocytes

A

councilman/apoptptic bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Liver damage in hepatitis

A
  • hepatitis cell degeneration and necrosis
  • cell dropout
  • ballooning of cells
  • acidophilic degeneration of hepatocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Large hepatocytes with ground glass appearance

A

chronic hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

paucity of inflammation
increase in activation of sinusoidal lining cells
lymphoid aggregate

A

Hepa C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hepatitis

microvesicular steatosis

A

Hepa D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

common histologic feature is marked cholestasis

A

Hep E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Component of the “bridge”

A
  1. condensed reticulum
  2. inflammatory debris
  3. degenerating liver cells that span adjacent portal areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

fulminant hepatitis

“acute yellow atrophy”

A

massive hepatic necrosis

17
Q

subacute or confluent necrosis

interface hepatitis

A

bridging hepatic necrosis

18
Q

AE of interferon therapy for Hepa B that is not reversible upon dose lowering

A

Autoimmune hepatitis

19
Q

High risk individuals that should receive screening for hep B

A

CHIMPA h-3 i-3 m-2

Countries endemic
Household contacts
HCV/HIV patients
HD patients
Inmates
Injection drugs
Immunosuppressed
MSM
Multiple sex contacts
Pregnant
ALT or AsT elevated
20
Q

Jaundice in sclera

A

> 43 umol or 2.5 mg/dl

21
Q

First approved therapy for hepa B

22
Q

MOA lamivudine

A

Inhibits reverse transcriptase activity of HIV and HBV

23
Q

Monotherapy of ____ can induce YMDD variants in patients with HIV infection

24
Q

First line therapy of choice in HBeAg reactive chronic hepatitis B

A

PEG IFN monotheraoy

25
antiviral therapy is recommended hepatitis
HBeAg-negative chronic hepatitis B ALT >2 x the upper limit of normal HBV DNA >2 x 103 IU/ml